Nour Sneige

Q: What Schools Are Affiliated With Nour Sneige

Nour Sneige is affiliated with the following schools: MD Anderson Cancer Center, Chosun University

Nour Sneige's AcademicInfluence.com Rankings

Nour Sneige

Philosophy

#9801

World Rank

#13414

Historical Rank

Logic

#6758

World Rank

#8305

Historical Rank

philosophy Degrees

Download Badge

Philosophy

Why Is Nour Sneige Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Nour Sneige's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Clinical course of breast cancer patients with complete pathologic primary tumor and axillary lymph node response to doxorubicin-based neoadjuvant chemotherapy. (1999) (1301)
Pharmacogenomic predictor of sensitivity to preoperative chemotherapy with paclitaxel and fluorouracil, doxorubicin, and cyclophosphamide in breast cancer. (2006) (714)
Phase II study of weekly docetaxel and trastuzumab for patients with HER-2-overexpressing metastatic breast cancer. (2002) (571)
Gene expression profiles predict complete pathologic response to neoadjuvant paclitaxel and fluorouracil, doxorubicin, and cyclophosphamide chemotherapy in breast cancer. (2004) (556)
Outcome after pathologic complete eradication of cytologically proven breast cancer axillary node metastases following primary chemotherapy. (2005) (369)
Role of ultrasound‐guided fine‐needle aspiration of indeterminate and suspicious axillary lymph nodes in the initial staging of breast carcinoma (2002) (345)
RTOG 9804: a prospective randomized trial for good-risk ductal carcinoma in situ comparing radiotherapy with observation. (2015) (318)
Invasive lobular carcinoma classic type: response to primary chemotherapy and survival outcomes. (2005) (288)
Diagnostic pitfalls in thyroid fine‐needle aspiration: A review of 394 cases (1993) (224)
Gene expression profiles obtained from fine-needle aspirations of breast cancer reliably identify routine prognostic markers and reveal large-scale molecular differences between estrogen-negative and estrogen-positive tumors. (2003) (218)
HER-2/neu gene amplification compared with HER-2/neu protein overexpression and interobserver reproducibility in invasive breast carcinoma. (2000) (211)
Radiofrequency ablation of solid tumors. (2001) (207)
Small (< or = 2-cm) breast cancer treated with US-guided radiofrequency ablation: feasibility study. (2004) (204)
Her-2/neu overexpression and amplification in uterine papillary serous carcinoma. (2004) (202)
Cationic liposome-mediated E1A gene transfer to human breast and ovarian cancer cells and its biologic effects: a phase I clinical trial. (2001) (200)
Parapharyngeal and Retropharyngeal Space Diseases (1989) (188)
Clinical, Histopathologic, and Biologic Features of Pleomorphic Lobular (Ductal-Lobular) Carcinoma In Situ of the Breast: A Report of 24 Cases (2002) (187)
Total RNA yield and microarray gene expression profiles from fine‐needle aspiration biopsy and core‐needle biopsy samples of breast carcinoma (2003) (179)
Relative value of physical examination, mammography, and breast sonography in evaluating the size of the primary tumor and regional lymph node metastases in women receiving neoadjuvant chemotherapy for locally advanced breast carcinoma. (1997) (178)
Determination of oestrogen-receptor status and ERBB2 status of breast carcinoma: a gene-expression profiling study. (2007) (176)
Comparison of HER‐2 status determined by fluorescence in situ hybridization in primary and metastatic breast carcinoma (2005) (170)
Fine-needle aspiration biopsy of nonpalpable breast lesions in a multicenter clinical trial: results from the radiologic diagnostic oncology group V. (2001) (170)
Randomized trial of high-dose chemotherapy and blood cell autografts for high-risk primary breast carcinoma. (2000) (169)
Rate of insufficient samples for fine‐needle aspiration for nonpalpable breast lesions in a multicenter clinical trial (1998) (167)
Progressive decrease in nuclear retinoic acid receptor beta messenger RNA level during breast carcinogenesis. (1997) (160)
Estrogen Receptor Analysis for Breast Cancer: Current Issues and Keys to Increasing Testing Accuracy (2005) (151)
Expression of growth factor and chemokine receptors: new insights in the biology of inflammatory breast cancer. (2007) (148)
Endoscopic ultrasound‐guided fine‐needle aspiration in 179 cases (2002) (147)
Inflammatory breast cancer (IBC) and patterns of recurrence (2007) (142)
Lobular Carcinoma In Situ Diagnosed By Core Needle Biopsy: When Should It Be Excised? (2003) (141)
Fine-Needle Aspiration of Salivary Glands: Its Utility and Tissue Effects (1992) (141)
Plasmacytoid transitional cell carcinoma. Report of a case with initial presentation mimicking multiple myeloma. (1991) (136)
Thyroid Transcription Factor-1 Expression in Endometrial and Endocervical Adenocarcinomas (2007) (131)
Accuracy of core needle biopsy diagnosis in assessing papillary breast lesions: histologic predictors of malignancy (2004) (126)
Triple Negative Breast Carcinoma and the Basal Phenotype: From Expression Profiling to Clinical Practice (2007) (126)
Prognosis of surgically determined complete responders in advanced ovarian cancer (1985) (116)
Sonographic appearance and ultrasound‐guided fine‐needle aspiration biopsy of breast carcinomas smaller than 1 cm3. (1990) (114)
Atypical ductal hyperplasia diagnosis by directional vacuum-assisted stereotactic biopsy of breast microcalcifications. Considerations for surgical excision. (2003) (112)
The Prognostic Significance of Peritoneal Cytology for Stage I Endometrial Cancer (1989) (112)
Morphologic and immunocytochemical evaluation of 220 fine needle aspirates of malignant lymphoma and lymphoid hyperplasia. (1990) (111)
Fine-needle aspiration cytology of metastatic neoplasms in the breast. (1989) (106)
Distinction of phyllodes tumor from fibroadenoma (2000) (104)
Implementation of American Society of Clinical Oncology/College of American Pathologists HER2 Guideline Recommendations in a tertiary care facility increases HER2 immunohistochemistry and fluorescence in situ hybridization concordance and decreases the number of inconclusive cases. (2009) (103)
Ultrasound‐guided fine‐needle aspiration (FNA) of nonpalpable breast lesions (1999) (101)
Predicting degree of benefit from adjuvant trastuzumab in NSABP trial B-31. (2013) (101)
Predictors of invasion in patients with core‐needle biopsy‐diagnosed ductal carcinoma in situ and recommendations for a selective approach to sentinel lymph node biopsy in ductal carcinoma in situ (2006) (98)
CD44 Expression Is Associated with Increased Survival in Node-Negative Invasive Breast Carcinoma (2005) (97)
Clinical, Histopathologic, and Immunohistochemical Features of Microglandular Adenosis and Transition Into In Situ and Invasive Carcinoma (2008) (97)
Evaluation of a Commercialized In Situ Hybridization Assay for Detecting Human Papillomavirus DNA in Tissue Specimens from Patients with Cervical Intraepithelial Neoplasia and Cervical Carcinoma (2007) (95)
Pathologic tumor size and lymph node status predict for different rates of locoregional recurrence after mastectomy for breast cancer patients treated with neoadjuvant versus adjuvant chemotherapy. (2002) (92)
Low-Grade (Fibromatosis-Like) Spindle Cell Carcinoma of the Breast (2001) (90)
Oat cell carcinoma of the urinary tract. An immunohistochemical and electron microscopic study (1986) (90)
Atypical Ductal Hyperplasia in Directional Vacuum-Assisted Biopsy of Breast Microcalcifications: Considerations for Surgical Excision (2011) (90)
Microscopic disease at second‐look laparotomy in advanced ovarian cancer (1985) (89)
Endodermal sinus tumor of the vagina and cervix (1985) (89)
Locoregional recurrence after doxorubicin-based chemotherapy and postmastectomy: Implications for breast cancer patients with early-stage disease and predictors for recurrence after postmastectomy radiation. (2003) (89)
Specimen adequacy and false‐negative diagnosis rate in fine‐needle aspirates of palpable breast masses (1998) (88)
Immunohistochemical characterization of subtypes of male breast carcinoma (2009) (88)
Transthoracic fine-needle aspiration vs concurrent core needle biopsy in diagnosis of intrathoracic lesions: a retrospective comparison of diagnostic accuracy. (2006) (85)
Can FNA biopsy separate atypical hyperplasia, carcinoma in situ, and invasive carcinoma of the breast?: Cytomorphologic criteria and limitations in diagnosis (1993) (84)
Fine‐needle aspiration of the breast: A review of 1,995 cases with emphasis on diagnostic pitfalls (1993) (81)
Imaging differences in metaplastic and invasive ductal carcinomas of the breast. (2007) (80)
Reliability of chromogenic in situ hybridization for detecting HER-2 gene status in breast cancer: comparison with fluorescence in situ hybridization and assessment of interobserver reproducibility (2005) (79)
Abnormal expression of MDM-2 in breast carcinomas (2005) (79)
Optimal fixation conditions for immunocytochemical analysis of estrogen receptor in cytologic specimens of breast carcinoma (2003) (78)
Fine-needle aspiration cytology of ductal hyperplasia with and without atypia and ductal carcinoma in situ. (1994) (78)
Radiofrequency ablation of early-stage invasive breast tumors: an overview. (2002) (77)
Bartholin gland carcinoma (1986) (77)
Ductal carcinoma in situ treated with lumpectomy and irradiation: histopathological analysis of 49 specimens with emphasis on risk factors and long term results. (1995) (74)
Fibrosarcoma of ovary. A new component in the nevoid basal-cell carcinoma syndrome. (1984) (74)
Paclitaxel in the multimodality treatment for inflammatory breast carcinoma (2001) (73)
Choanal and Angiomatous Polyps of the Sinonasal Tract (1992) (72)
Intraoperative touch imprint of sentinel lymph nodes in breast carcinoma patients (2002) (70)
Mucocelelike tumor of the breast associated with atypical ductal hyperplasia or mucinous carcinoma. A clinicopathologic study of seven cases. (1991) (70)
Metaplastic Sarcomatoid Carcinoma of the Breast With Absent or Minimal Overt Invasive Carcinomatous Component: A Misnomer (2005) (70)
Distribution and viral load of eight oncogenic types of human papillomavirus (HPV) and HPV 16 integration status in cervical intraepithelial neoplasia and carcinoma (2007) (69)
Sources of diagnostic error in the fine‐needle aspiration diagnosis of Warthin's tumor and clues to a correct diagnosis (1997) (67)
Polycomb group protein EZH2 is frequently expressed in inflammatory breast cancer and is predictive of worse clinical outcome (2011) (67)
Her-2/neu gene amplification in ductal carcinoma in situ of the breast. (2002) (66)
Amyloidosis in the Upper Aerodigestive Tracts (1992) (65)
Metastatic hidradenocarcinoma with demonstration of Her‐2/neu gene amplification by fluorescence in situ hybridization: potential treatment implications (2007) (65)
Quality‐assurance study of simultaneously sampled, non‐correlating cervical cytology and biopsies (1993) (64)
Fine‐needle aspiration of pancreatic serous cystadenoma (2006) (63)
β4 integrin subunit gene expression correlates with tumor size and nuclear grade in early breast cancer (2005) (63)
Assessment of Two Automated Imaging Systems in Evaluating Estrogen Receptor Status in Breast Carcinoma (2007) (63)
Interobserver agreement for estrogen receptor immunohistochemical analysis in breast cancer: a comparison of manual and computer-assisted scoring methods. (2004) (62)
Efficacy of p16 and ProExC immunostaining in the detection of high-grade cervical intraepithelial neoplasia and cervical carcinoma. (2011) (62)
Clinical implications of margin involvement by pleomorphic lobular carcinoma in situ. (2011) (59)
Stability of estrogen receptor status in breast carcinoma (2011) (59)
The utility of endobronchial ultrasound‐guided transbronchial needle aspiration biopsy in the diagnosis of mediastinal lymphoproliferative disorders (2011) (59)
p53 Expression as a Prognostic Marker in Inflammatory Breast Cancer (2004) (58)
Validation of commonly used immunostains on cell‐transferred cytologic specimens (2005) (58)
Interobserver reproducibility of the Lagios nuclear grading system for ductal carcinoma in situ. (1999) (57)
Sonographic and mammographic appearances of granular cell tumors of the breast with pathological correlation (2006) (56)
Molecular and Biologic Markers of Premalignant Lesions of Human Breast (2002) (55)
Cervical adenocarcinoma: tumor implantation in the episiotomy sites of two patients. (1987) (54)
Papillary renal‐cell carcinoma: Fine‐needle aspiration of 15 cases (1991) (52)
Most lobular carcinoma in situ and atypical lobular hyperplasia diagnosed on core needle biopsy can be managed clinically with radiologic follow-up in a multidisciplinary setting (2014) (52)
Stability of HER2-positive status in breast carcinoma: a comparison between primary and paired metastatic tumors with regard to the possible impact of intervening trastuzumab treatment. (2011) (50)
Ultrasound-guided fine-needle aspiration of nonpalpable breast lesions. Cytologic and histologic findings. (1994) (49)
Molecular and biomarker analyses of salivary duct carcinomas: comparison with mammary duct carcinoma. (2001) (49)
Breast carcinoma arising in microglandular adenosis: a review of the literature. (2007) (48)
Nipple aspirate fluid cytology in breast carcinoma (2002) (47)
Molecular evidence in support of the neoplastic and precursor nature of microglandular adenosis (2012) (46)
Value of PAX8 and WT1 Immunostaining in Confirming the Ovarian Origin of Metastatic Carcinoma in Serous Effusion Specimens. (2012) (45)
Giant cell tumor of bone. A cytologic study of 24 cases (1985) (45)
A single-gene biomarker identifies breast cancers associated with immature cell type and short duration of prior breastfeeding. (2005) (44)
Interventional breast sonography. (2002) (44)
Collagenous Spherulosis of Breast: Morphologic Study of 59 Cases and Review of the Literature (2006) (43)
Utility of cytologic specimens in the evaluation of prognostic and predictive factors of breast cancer: Current issues and future directions (2004) (42)
Phase II clinical trial of N-(4-Hydroxyphenyl)retinamide and tamoxifen administration before definitive surgery for breast neoplasia. (2002) (42)
Fine‐needle aspiration cytology of the male breast in a cancer center (1993) (42)
Effects of a green tea extract, Polyphenon E, on systemic biomarkers of growth factor signalling in women with hormone receptor-negative breast cancer. (2015) (42)
Quantitative nuclear morphometry by image analysis for prediction of recurrence of ductal carcinoma in situ of the breast. (2001) (42)
Quantitative analysis of chromosome in situ hybridization signal in paraffin-embedded tissue sections. (1994) (41)
A plea for uniform terminology and reporting of breast fine needle aspirates. M.D. Anderson Cancer Center proposal. (1994) (41)
HER‐2/NEU gene amplification in breast imprint cytology analyzed by fluorescence in situ hybridization: Direct comparison with companion tissue sections (2000) (39)
Expression of BAG-1 and BcL-2 Proteins Before and After Neoadjuvant Chemotherapy of Locally Advanced Breast Cancer (2004) (39)
Use of monoclonal antibody HMB-45 in the cytologic diagnosis of melanoma. (1988) (39)
Peritoneal washing cytology in women: Diagnostic pitfalls and clues for correct diagnosis (1992) (38)
Beta4 integrin subunit gene expression correlates with tumor size and nuclear grade in early breast cancer. (2005) (38)
Fine‐needle aspiration cytology in pancreatic endocrine tumors (1987) (38)
Recurrence in autogenous myocutaneous flap reconstruction after mastectomy for primary breast cancer: US diagnosis. (2003) (38)
Neuroendocrine (Merkel cell) carcinoma of the vulva: a case report and review of the literature. (1985) (38)
Alveolar rhabdomyosarcoma of the female genitalia (1985) (38)
Müllerian inclusions in peritoneal washings. Potential source of error in cytologic diagnosis. (1986) (36)
The Use of TMA for Interlaboratory Validation of FISH Testing for Detection of HER2 Gene Amplification in Breast Cancer (2004) (36)
Benign papillomas without atypia diagnosed on core needle biopsy: experience from a single institution and proposed criteria for excision. (2013) (36)
Diagnosis of lymphoma and reactive lymphoid hyperplasia by immunocytochemical analysis of fine‐needle aspiration biopsy (1990) (35)
Age as a predictor of outcome for women with DCIS treated with breast-conserving surgery and radiation: The University of Texas M. D. Anderson Cancer Center experience. (2002) (34)
Histologic Localization of Sentinel Lymph Node Metastases in Breast Cancer (2003) (34)
High and differential expression of HER-2/neu extracellular domain in bilateral ductal fluids from women with unilateral invasive breast cancer. (2003) (34)
Prognosis of gastric adenocarcinoma patients with various burdens of peritoneal metastases (2016) (34)
The role of gene rearrangements for antigen receptors in the diagnosis of lymphoma obtained by fine-needle aspiration. A study of 63 cases with concomitant immunophenotyping. (1991) (33)
Comparison of Ductal Lavage and Random Periareolar Fine Needle Aspiration as Tissue Acquisition Methods in Early Breast Cancer Prevention Trials (2007) (33)
Fine-needle aspiration cytology and flow cytometry of intracystic papillary carcinoma of breast. (1990) (33)
Detection of numerical aberrations of chromosomes 7 and 9 in cytologic specimens of pleural malignant mesothelioma (2003) (32)
Fine‐needle aspiration cytology of sclerosing hemangioma of the lung: Case report with immunohistochemical study (1993) (31)
Fine‐needle aspiration cytology of pediatric patients with primary hepatic tumors: A comparative study of two hepatoblastomas and a liver‐cell carcinoma (1988) (29)
Masses in breasts with implants: diagnosis with US-guided fine-needle aspiration biopsy. (1994) (29)
Interphase cytogenetics in mammographically detected breast lesions. (1996) (28)
Correlation of cytologic findings and chromosomal instability detected by fluorescence in situ hybridization in breast fine-needle aspiration specimens from women at high risk for breast cancer (2006) (28)
Fine-needle aspiration of adrenal cortical carcinoma: cytologic spectrum and diagnostic challenges. (2006) (28)
Prognostic significance of equivocal human epidermal growth factor receptor 2 results and clinical utility of alternative chromosome 17 genes in patients with invasive breast cancer: A cohort study (2017) (28)
Flow cytometric (DNA content and S‐phase fraction) analysis of breast cancer (1993) (28)
Laryngeal paraganglioma. Report of two tumors with immunohistochemical and ultrastructural analysis. (1983) (28)
The feasibility of gene expression profiling generated in fine‐needle aspiration specimens from patients with follicular lymphoma and diffuse large B‐cell lymphoma (2005) (27)
Flow cytometric analysis of apoptosis and bcl-2 in primary breast carcinomas: clinical and biological implications. (1996) (27)
Adenovirus type 5 E1A gene therapy for ovarian clear cell carcinoma: a potential treatment strategy (2007) (26)
Novel translational model for breast cancer chemoprevention study: accrual to a presurgical intervention with tamoxifen and N-[4-hydroxyphenyl] retinamide. (2000) (26)
Fine‐needle aspiration cytology of a liver metastasis of follicular dendritic cell sarcoma (2005) (26)
Secondary tumors of the pancreas diagnosed by endoscopic ultrasound‐guided fine‐needle aspiration: A 10‐year experience (2014) (26)
EZH2 expression correlates with locoregional recurrence after radiation in inflammatory breast cancer (2012) (26)
Peritoneal washing cytologic analysis of ovarian serous tumors of low malignant potential to detect peritoneal implants and predict clinical outcome (2012) (26)
Should specimen adequacy be determined by the opinion of the aspirator or by the cells on the slides? (1997) (25)
In search of specimen adequacy in fine-needle aspirates of nonpalpable breast lesions. (1997) (25)
Impact of concurrent proliferative high‐risk lesions on the risk of ipsilateral breast carcinoma recurrence and contralateral breast carcinoma development in patients with ductal carcinoma in situ treated with breast‐conserving therapy (2006) (25)
Invasive Paget Disease of the Breast: Clinicopathologic Study of an Underrecognized Entity in the Breast (2012) (25)
Author reply (2007) (25)
Interobserver agreement of a probabilistic approach to reporting breast fine‐needle aspirations on ThinPrep® (2004) (25)
Performance of chromogenic in situ hybridization on testing HER2 Status in breast carcinomas with chromosome 17 polysomy and equivocal (2+) herceptest results: a study of two institutions using the conventional and new ASCO/CAP scoring criteria. (2009) (25)
Impact of extensive intraductal component on recurrence and survival in patients with stage I or II breast cancer treated with breast conservation therapy (2006) (24)
Prognostic value of P53, MDM‐2, and MUC‐1 for patients with inflammatory breast carcinoma (2004) (24)
Chromogenic in situ hybridization is a reliable method for detecting HER2 gene status in breast cancer: a multicenter study using conventional scoring criteria and the new ASCO/CAP recommendations. (2009) (24)
Pseudoparasitic Liesegang structures in perirenal hemorrhagic cysts. (1988) (24)
Phase III randomized trial of dose intensive neoadjuvant chemotherapy with or without G-CSF in locally advanced breast cancer: long-term results. (2011) (23)
Pathologic Predictors of Tumor Response to Preoperative Chemotherapy in Locally Advanced Breast Carcinoma (1995) (23)
Endobronchial ultrasound-guided transbronchial needle aspiration biopsy is useful evaluating mediastinal lymphadenopathy in a cancer center (2011) (23)
Comparison of immunocytochemical and biochemical assays for estrogen receptor in fine needle aspirates and histologic sections from breast carcinomas (1990) (23)
Pseudoparasitic (Liesegang) bodies in paranasal sinus (1988) (22)
Comparison of the accuracy of US-guided biopsy of breast masses performed with 14-gauge, 16-gauge and 18-gauge automated cutting needle biopsy devices, and review of the literature (2017) (22)
Liesegang-like rings in fine needle aspirates of renal/perirenal hemorrhagic cysts. (1988) (21)
Human papillomavirus genotyping for the eight oncogenic types can improve specificity of HPV testing in women with mildly abnormal Pap results (2008) (21)
Paneth cell-like eosinophilic cytoplasmic granules in breast carcinoma. (2011) (21)
Metastases to intramammary lymph nodes in patients with breast cancer: Sonographic findings (2008) (21)
Immunohistochemical demonstration of multiple neurohormonal polypeptides in a case of pure testicular carcinoid. (1982) (21)
Downregulation of the cyclin-dependent kinase inhibitor p27kip1 might correlate with poor disease-free and overall survival in inflammatory breast cancer. (2006) (20)
Peritoneal washing cytology in patients with BRCA1 or BRCA2 mutations undergoing risk-reducing salpingo-oophorectomies: a 10-year experience and reappraisal of its clinical utility. (2012) (20)
Flat epithelial atypia in directional vacuum-assisted biopsy of breast microcalcifications: surgical excision may not be necessary (2018) (20)
Chemotherapy-induced histologic changes in mastectomy specimens and their potential significance. (2001) (20)
Cervical carcinoma DNA content, S-fraction, and malignancy grading. I. Interrelationships. (1987) (20)
Randomized Phase III Trial Evaluating Radiation Following Surgical Excision for Good-Risk Ductal Carcinoma In Situ: Long-Term Report From NRG Oncology/RTOG 9804 (2021) (19)
Neovascularization in mucinous ductal carcinoma in situ suggests an alternative pathway for invasion (2008) (19)
Characterization of foam cells in nipple aspirate fluid (2002) (18)
Quantitation of immunocytochemical estrogen and progesterone receptor content in fine needle aspirates of breast carcinoma using the SAMBA 4000 image analysis system. (1993) (18)
Immunocytochemical evaluation of estrogen receptor on archival Papanicolaou‐stained fine‐needle aspirate smears (2003) (17)
Evaluation of p16 immunostaining to predict high‐grade cervical intraepithelial neoplasia in women with Pap results of atypical squamous cells of undetermined significance (2011) (17)
Correlation of two AgNOR counts with Ki‐67 labeling index: A study in fine‐needle aspirates of lymphoproliferative disorders and breast carcinoma (1994) (17)
Fine-needle aspiration cytology of sclerosing adenosis of the breast: a retrospective review of cytologic features in conjunction with corresponding histologic features and radiologic findings. (2012) (17)
Stromal neoplasms of the breast: A comparative flow cytometric study (1990) (17)
Ovarian and omental ependymomas in peritoneal washings: Cytologic and immunocytochemical features (1986) (17)
Microscopic disease at second-look laparotomy in advanced ovarian cancer. (1983) (17)
Correlation of interleukin 6 with interleukin 1alpha in human mammary tumours, but not with oestrogen receptor expression. (1998) (16)
Phase I biomarker modulation study of atorvastatin in women at increased risk for breast cancer (2016) (16)
Expression of high-molecular-weight cytokeratin (34βE12) is an independent predictor of disease-free survival in patients with triple-negative tumours of the breast (2010) (16)
Breast carcinoma with choriocarcinomatous features. (2004) (16)
Fine Needle Aspiration Cytology of Well-Differentiated Papillary Mesothelioma (2005) (15)
Objective comparison of cellular yield in fine‐needle biopsy of lymph nodes with and without aspiration (1993) (15)
Fine needle aspiration cytology of extramedullary chronic myelogenous leukemia. (1995) (15)
Endosalpingiosis in peritoneal washings in women with benign gynecologic conditions (2013) (14)
Fine needle aspiration cytology of thymolipoma. A case report. (1987) (14)
Feasibility and utility of using chromosomal aneusomy to further define the cytologic categories in nipple aspirate fluid specimens (2004) (14)
Hypomagnesaemia-induced hypocalcaemia: concentrations of parathyroid hormone, prolactin and 1,25-dihydroxyvitamin D during magnesium replenishment. (1992) (14)
Primary Tumors of the Facial (Extracranial) Nerve (1991) (13)
Myospherulosis. Fine needle aspiration cytologic findings in 19 cases. (1991) (13)
Cervical carcinoma DNA content, S-fraction, and malignancy grading. II. Comparison with clinical staging. (1987) (13)
Interphase nucleolar organizer regions in the evaluation of serosal cavity effusions. (1994) (13)
Ultrasound-guided fine-needle aspiration biopsy of internal mammary nodes: technique and preliminary results in breast cancer patients. (2014) (13)
Mammographic-pathologic correlation of apocrine metaplasia diagnosed using vacuum-assisted stereotactic core-needle biopsy: our 4-year experience. (2003) (13)
A NEW COMPONENT IN THE NEVOID BASAL-CELL CARCINOMA SYNDROME (1984) (12)
Monosomy 21, partial duplication of chromosome 11, and structural abnormality of chromosome 1q21 in a case of lymphoma developing in a transplant recipient: characteristic abnormalities of secondary lymphoma? (1987) (12)
Is it too soon to start reporting HER2 genetic heterogeneity? (2010) (12)
Low-risk Breast Ductal Carcinoma In Situ (DCIS): Results From the Radiation Therapy Oncology Group 9804 Phase 3 Trial (2012) (12)
Fine-needle aspiration of the breast: diagnostic problems and approaches to surgical management. (1994) (12)
Tumor type and single‐cell/mesothelial‐like cell pattern of breast carcinoma metastases in pleural and peritoneal effusions (2012) (12)
Strategies for the application of biomarkers for risk assessment and efficacy in breast cancer chemoprevention trials (1993) (11)
The role of human papillomavirus type 16/18 genotyping in predicting high‐grade cervical/vaginal intraepithelial neoplasm in women with mildly abnormal Papanicolaou results (2013) (11)
Pathology consultation. Necrotizing sialometaplasia (1992) (10)
Measurements of estrogen receptor and reporter genes from microarrays determine receptor status and time to recurrence following adjuvant tamoxifen therapy. (2005) (10)
Intraluminal crystalloids in breast carcinoma. Immunohistochemical, ultrastructural, and energy-dispersive x-ray element analysis in four cases. (1997) (10)
p53 and c-erbB-2 expression and response to preoperative chemotherapy in locally advanced breast carcinoma (1995) (10)
Utility of punch biopsy for lesions that are hard to aspirate by conventional fine‐needle aspiration (1999) (10)
Fine-needle aspiration cytology of in situ epithelial cell proliferation in the breast. (2000) (9)
Technical approach for the study of the genetic evolution of breast cancer from paraffin-embedded tissue sections (2005) (9)
Computerized image analysis of Ki-67 in ductal breast carcinoma in situ. (2001) (9)
A compatison of fine-needle aspiration, core biopsy, and needle localization biopsy techniques inn mammographyically detectable nonpalpable breast lesions (1996) (9)
A nomogram to predict for malignant diagnosis of BI‐RADS category 4 breast lesions (2010) (8)
Three‐year risk of high‐grade CIN for women aged 30 years or older who undergo baseline Pap cytology and HPV co‐screening (2017) (8)
Intracystic papillary carcinoma of the breast [2] (1991) (7)
Pathologic quiz case: a large, ill-defined cystic breast mass. Invasive cystic hypersecretory duct carcinoma. (2005) (7)
No increased Ki67 expression in ductal carcinoma in situ associated with invasive breast cancer. (2001) (7)
Abstract CN04-04: Phase II trial of bexarotene in women at high risk of breast cancer: Comparison of protein and RNA biomarkers (2008) (7)
Clinical relevance of HER-2 amplification and overexpression in human cancers (2000) (6)
Chromogenic In Situ Hybridization Is a Reliable Method for Detecting HER 2 Gene Status in Breast Cancer (2009) (6)
Coaxial core needle biopsy under mammographic guidance: indications and applications. (1998) (5)
Web based pathology assessment in RTOG 98-04 (2014) (5)
Bivariate RNA and DNA content analysis in breast carcinoma: biological significance of RNA content. (1996) (5)
RNA yield from needle biopsies for cDNA microarray analysis of breast cancer prior to neoadjuvant chemotherapy (2001) (5)
Identifying patients with atypical ductal hyperplasia diagnosed at core-needle biopsy who are at low risk of malignancy. (2010) (5)
Clinical Management of Mucocele-Like Lesions of the Breast with Limited or no Epithelial Atypia on Core Biopsy: Experience from Two Institutions (2019) (5)
Invasive lobular carcinoma (ILC) "classic type": Distinct clinical features. (2004) (4)
Necrotizing Sialometaplasia (1992) (4)
Fine‐needle aspiration cytology of recurrent and metastatic mixed mesodermal tumors (1994) (4)
Fine-Needle Aspiration versus Core Needle Biopsy for Diagnosis of Nonpalpable and Palpable Breast Lesions (1999) (4)
Short-Term Biomarker Modulation Prevention Study of Anastrozole in Women at Increased Risk for Second Primary Breast Cancer (2011) (4)
Primary multifocal angiosarcoma of the breast. Sonographic evaluation with pathologic correlation. (1990) (4)
Stereologic estimates of volume-weighted mean nuclear volume in aspiration smears of ductal breast carcinoma. Correlation with cytologic grade, tumor size and lymph node status. (1999) (4)
A Human Papillomavirus Testing System in Women with Abnormal Pap Results (2007) (4)
HER2 testing in breast cancers: comparison of assays and interpretation using ASCO/CAP 2013 and 2018 guidelines (2021) (4)
Phase II study of weekly docetaxel (Taxotere; txt) and trastuzumab (Herceptin; H) for patients with HER-2 overexpressing (HER2+) metastatic breast cancer (MBC) (2001) (4)
Primary chemotherapy for breast cancer — MD Anderson experience (1991) (4)
Image analysis--derived morphometric differences in fine needle aspirates of ductal and lobular breast carcinoma. (1995) (4)
Phase II prevention trial of celecoxib in women at increased risk for breast cancer (2007) (4)
Prognosis of gastric cancer (GC) patients with positive peritoneal cytology. (2015) (3)
Image-Guided Biopsies of the Breast: Technical Considerations, Diagnostic Challenges, and Postbiopsy Clinical Management (2008) (3)
A randomized, parallel-arm, phase II trial to assess the efficacy of preoperative ixabepilone with or without cetuximab in patients with triple-negative breast cancer (TNBC). (2014) (3)
Translational Research Program (2001) (3)
Phyllodes tumors of the breast (1995) (3)
Diagnostic Approaches to the Pathology of Primary Breast Cancer Before and After Neoadjuvant Chemotherapy (2004) (3)
The clinical impact of proliferative high-risk lesions presenting concurrently with ductal carcinoma in situ (DCIS) in patients (pts) treated with breast conserving therapy (BCT) (2005) (3)
Radiation Therapy Oncology Group. Research Plan 2002-2006. Breast Cancer Working Group. (2001) (2)
Biomarker Modulation Study of Celecoxib for Chemoprevention in Women at Increased Risk for Breast Cancer: A Phase II Pilot Study (2020) (2)
Pathologic Quiz Case: A Large, Ill-Defined Cystic Breast Mass (2009) (2)
Utility of endoscopic ultrasound-guided fine-needle aspiration of regional lymph nodes that are proximal to and far from the primary distal esophageal carcinoma (2017) (2)
Interobserver Variability in the Classification of Proliferative Breast Lesions by Fine-Needle Aspiration: of the Papanicolaou Society (1998) (1)
The utility of claudin‐4 versus MOC‐31 and Ber‐EP4 in the diagnosis of metastatic carcinoma in cytology specimens (2022) (1)
Increased expression of chemokine receptors in inflammatory breast cancer: Implications for novel targeted therapies (2005) (1)
Glutathione S‐Transferase‐pi Expression in Prechemotherapy and Postchemotherapy Tumor Samples from Patients with Locally Advanced Breast Carcinomas (1996) (1)
Core Needle Biopsy and Needle Localization Biopsy of Nonpalpable Breast Lesions: Technical Considerations and Diagnostic Challenges (2001) (1)
Comparison between cytologic examination of fungi in bronchial washings and bronchoalveolar lavage specimens and culture: a review of 100 cases with emphasis on diagnostic pitfalls. (2014) (1)
Pathologic assessment of prognostic factors in patients with operable breast cancer (1993) (1)
Sinus Histiocytosis with Massive Lymphadenopathy (1989) (1)
Utility of endoscopic ultrasound-guided fine-needle aspiration of regional lymph nodes that are proximal to and far from the primary distal esophageal carcinoma. (2017) (1)
Evaluation of a Commercialized In Situ Hybridization Assay for Detecting Human Papillomavirus DNA in Cervical Intraepithelial Neoplasia and Cervical Carcinoma (2007) (1)
Radiation Therapy Oncology Group. Research Plan 2002-2006. Translational Research Program. (2001) (1)
A Large, Ill-Defined Cystic Breast Mass (2005) (1)
C-erbB-2 overexpression and gene amplification in human colon cancers (2000) (1)
Sarcoidosis and breast cancer (1992) (1)
EZH2 expression correlates with locoregional recurrence after radiation in inflammatory breast cancer (2014) (1)
Is surgical biopsy mandatory in case of atypical ductal hyperplasia on 11-gauge core needle biopsy? A retrospective study of 300 patients (2009) (1)
No Increased Ki 67 Expression in Ductal Carcinoma in Situ Associated with Invasive Breast Cancer 1 (2001) (1)
Regression of radiation- and chemotherapy-resistant non-small cell lung cancer treated with combination immunotherapy (1991) (0)
Radiation Therapy Oncology Group. Research Plan 2002-2006. Pathology Committee. (2001) (0)
Immunological and molecular studies in breast tumors (2012) (0)
Nephrogenic Adenomas (NA) in Bladder Washings/Urine Cytology Specimens: A Report of Eight Cases with Pax-8 Immunohistochemical Staining and Correlation with Surgical Biopsy Findings (2015) (0)
Efficacy of Reflex HPV Testing in Older, High-Risk Patients with an ASC-US Pap Result (2013) (0)
Breast (2019) (0)
Author reply (2023) (0)
Epithelial ovarian carcinoma: Pathologic deviations in patients with no macroscopic tumor at second-look (1987) (0)
Comparison of the accuracy of US-guided biopsy of breast masses performed with 18-gauge, 16-gauge and 14-gauge automated cutting needle biopsy devices (2015) (0)
0114: Adenovirus Type 5 E1A Gene Therapy for Ovarian Clear Cell Carcinoma: a Potential Treatment Strategy (2006) (0)
Percutaneous lymph node biopsy (1991) (0)
Gene Expression Profiles Obtained from Fine-Needle Aspirations of Breast Cancer Reliably Identify Routine Prognostic Markers and Reveal Large-Scale Molecular Differences between Estrogen-negative and Estrogen-positive Tumors 1 (2003) (0)
Atypical and columnar cell lesions in breast needle biopsies for indeterminate microcalcifications: predictors of higher risk findings requiring surgical excision. (2009) (0)
Sonographic evaluation of metastatic axillary lymph nodes in patients with breast cancer (2003) (0)
Diagnostic Yield of an Additional Gomori's Methenamine Silver-Stained Slide for Respiratory Specimens (2013) (0)
Secondary Tumors of the Pancreas Diagnosed by Endoscopic Ultrasound-Guided Fine Needle Aspiration: A Ten-Year Experience (2012) (0)
A quality assurance study involving pap smears; How the Bethesda system may improve the reading (1992) (0)
Comparison between Fungi Detected on Cytology Specimens and Microbiology Culture: A Review of 100 Cases with Emphasis on Diagnostic Pitfalls (2013) (0)
Accuracy of the EasyChip HPV blot genotyping assay in detecting high-risk HPV genotypes in SurePath Pap specimens (2016) (0)
Stability of Estrogen Receptor and HER2 Status Following Trastuzumab and Polychemotherapy Regimen. (2009) (0)
Abstract B17: Phase I prevention study of atorvastatin in women at increased risk for breast cancer (2012) (0)
Phase II breast cancer chemoprevention study with celecoxib in women at increased risk for breast cancer. (2006) (0)
Baseline proliferation markers and cytopathologic findings in breast epithelium of women at increased risk for breast cancer (2005) (0)
Clinical Performance of Cervista HPV HR and HC2 Co-testing with SurePath Pap Cytology (2015) (0)
Diagnostic Methodologies: Fine Needle Aspiration Cytology (2006) (0)
Phase II Clinical Trial of N-( 4-Hydroxyphenyl ) retinamide and Tamoxifen Administration before Definitive Surgery for Breast Neoplasia 1 (2002) (0)
A short-term biomarker modulation prevention study of anastrazole in women at increased risk for breast cancer. (2009) (0)
Feasibility of Gene Expression Profiling Generated from Fine Needle Aspiration from Patients with Follicular Lymphoma and Large B-Cell Lymphoma. (2004) (0)
Mammary mesenchymal and fibroepithelial lesions: An illustrated cytomorphologic update with differential diagnoses (2019) (0)
Aberrant DNA Methylation of SOX1 and PAX1 in Pap Specimens: Potential Biomarkers of Cervical Intraepithelial Neoplasm Grade 3 (2013) (0)
Cytology of Epithelial Proliferative Lesions and High-Grade Ductal Carcinoma In Situ (2013) (0)
Cyclooxygenase-2 is frequently overexpressed in human breast cancers (2001) (0)
Endosalpingiosis in Peritoneal Washings in Women with Benign Gynecologic Conditions: A Report of 34 Cases Confirmed with Pax-8 Immunohistochemical Staining and Correlation with Surgical Biopsy Findings (2012) (0)
Predictive Value of the Paris System for Reporting Urinary Cytology for High-grade Urothelial Carcinoma in Renal Pelvic Washing Specimens (2020) (0)
Clinical presentation of ductal carcinoma in situ of breast with intraluminal crystalloids: Radiologic-histologic correlation. (2018) (0)
Risk of CIN2+ in Women 30 Years and Older with Negative Pap and Positive Hybrid Capture 2 HPV DNA Testing Results (2012) (0)
Anatomic Pathology / DIAGNOSING ATYPICAL DUCTAL HYPERPLASIA BY DIRECTIONAL VACUUM-ASSISTED STEREOTACTIC BIOPSY (2003) (0)
ductal Lavage for Breast Cancer Risk Assessment (2003) (0)
Performance of Hybrid Capture 2 and Cervista HR HPV Testing Assays for Women with Atypical Squamous Cell of Undetermined Significance Pap Test Results in Cervical Cancer Screening vs. Surveillance Population (2018) (0)
Human papillomavirus and cervical disease in a Mexican-American community. (1986) (0)
Can HPV Testing Be Used as a First-line Screening Test for Cervical Cancer Prevention? Three-year Cumulative Risk of CIN2+ In Women Aged 30 Years and Older Screened by Pap and HPV Co-testing (2014) (0)
STK15/BTAK/aurora-A expression in ductal carcinoma in situ of the breast (2001) (0)
Three-Year Follow-up for Women 30 Years and Older with Negative Pap and Negative Hybrid Capture 2 HPV DNA Testing Results (2012) (0)
Abstract P5-07-08: The clinical utility of alternative chromosome 17 probes in equivocal HER2 results (2016) (0)
The bethesda system: Should condyloma be included in low grade squamous intraepithelial lesions (1992) (0)
Effect of acarbose on the need for between-meal snacking in patients with type 1 diabetes : a placebo-controlled, double-blind, cross-over study (1998) (0)
The Reliability of Ultrasound-guided Core Needle Biopsy in the Evaluation of Non-palpable Solid Breast Lesions Using 18-gauge Needles (2003) (0)
HER-2/neu Gene Amplification in Ductal Carcinoma In Situ of the Breast 1 (2002) (0)
Accuracy of EasyChip HPV blot genotyping assay to detect high-risk HPV genotypes in SurePath Papanicolaou specimens. (2016) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Nour Sneige?

Nour Sneige is affiliated with the following schools:

Nour Sneige's Academic­Influence.com Rankings

Why Is Nour Sneige Influential?

Nour Sneige's Published Works

Published Works

What Schools Are Affiliated With Nour Sneige?

Nour Sneige's AcademicInfluence.com Rankings